STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...
AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research ...
FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare ...
ACEMAGIC unveiled its latest Mini PC lineup at CES 2026, highlighting significant advancements in local AI computing, content creation and gaming ...
Morning Overview on MSN
Scientists found a safer path to boost calorie-burning cells
For decades, weight loss drugs have tried to coax the body into burning more energy, but the most aggressive approaches have ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
AZoLifeSciences on MSN
Turning human fat into insulin-producing organoids that reverse diabetes
By preserving fat tissue architecture, researchers created organoids that restore insulin function, paving the way for advancements in diabetes treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback